Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP consolidation chemotherapy for high-risk pediatric germ cell tumors (Phase II, non-randomized, open-label)
KCT0005355Phase 2Recruiting
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, cisplatin in germ cell tumor (GCT), blastoma, sponsored by JW Pharmaceutical Corporation. Started Jul 2024; status: recruiting.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
germ cell tumor (GCT)blastoma
Beyond the preview
Go deeper on KCT0005355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005355.